| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |